ASK REDCHAT ANYTHING ABOUT VAXART INC
Vaxart Inc (OTCQB: VXRT)
Listen to this Section
$0.60
-0.0199
(
-3.21% )
682.1K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| VXA-CoV2-1 (oral pill XBB)DetailsCOVID-19 |
Phase 2b |
| Oral Bivalent Norovirus VaccineDetailsInfectious disease, Norovirus |
Phase 1 |
| Monovalent Norovirus VaccineDetailsNorovirus, Infectious disease |
Phase 2 |
| VXA-A1.1DetailsInfluenza |
Phase 2 |
| Oral Bivalent Norovirus VaccineDetailsNorovirus, Infectious disease |
Phase 1 |
Market Data
|
| Open |
$0.60 |
| Previous Close |
$0.62 |
| Volume |
682.1K |
| Market Cap |
$145.21M |
| Day Range |
$0.58 - $0.62 |
| 52 Week Range |
$0.26 - $0.84 |
| Shares Outstanding |
241.97M |
| Change % |
-3.21% |
| Net Change |
▼ -0.0199 |
| Insider Ownership |
0.00% |
| Exchange |
OTCQB |
| Sector | Healthcare |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| IPO Year | |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-312,402.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2025-08-19 |
Buy |
794.00 |
Finney Kevin |
| 2025-07-31 |
Buy |
10000.00 |
Watson W. Mark |
| 2025-05-19 |
Buy |
100000.00 |
Lo Steven |
| 2024-06-20 |
Buy |
20000.00 |
Watson W. Mark |
| 2024-06-13 |
Sale |
-2007.00 |
Lee Phillip E |
| 2024-06-12 |
Sale |
-16000.00 |
HERON ELAINE J |
| 2024-06-12 |
Sale |
-16000.00 |
Watson W. Mark |
| 2024-06-12 |
Sale |
-16000.00 |
Yedid Robert A. |
| 2024-06-12 |
Sale |
-16000.00 |
Wheadon David E. |
| 2024-06-12 |
Sale |
-16000.00 |
Finney Michael J. |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 4 |
Insider transactions |
1 |
Aug 19, 2025 |
| 8-k |
8K-related |
14 |
Aug 15, 2025 |
| 8-k |
8K-related |
14 |
Aug 13, 2025 |
| 10-q |
Quarterly Reports |
75 |
Aug 13, 2025 |
| 8-k |
8K-related |
13 |
Aug 06, 2025 |
| def |
Proxies and info statements |
4 |
Aug 06, 2025 |
| 4 |
Insider transactions |
2 |
Jul 31, 2025 |
| pre |
Proxies and info statements |
4 |
Jul 24, 2025 |
| 8-k |
8K-related |
14 |
Jul 08, 2025 |
| 8-k |
8K-related |
13 |
Jul 02, 2025 |